Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2014-11-27 / Cancer Res Treat 2015 Jul;47(3):518-26CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
/in Dendritic Cells, International Publications /von 2014-11-26 / Biomaterials 2015 Feb;40:88-97Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-15Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
/in Dendritic Cells, International Publications /von 2014-11-15 / Immunobiology 2015 Feb;220(2):243-8Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
/in Cervical Cancer, Dendritic Cells, International Publications /von 2014-11-07 / Eur. J. Immunol. 2014 Dec;44(12):3585-95Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
/in International Publications, Newcastle Disease Virus, Thyroid Cancer /von 2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91Emerging treatment strategies for glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-70Perspectives for immunotherapy in glioblastoma treatment
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-11-01 / Curr Opin Oncol 2014 Nov;26(6):608-14
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution